Promising monoclonal antibody joins fight against Alzheimer’s
Phase 3 trial results published in JAMA show donanemab slows cognitive decline in most participants with early Alzheimer’s. Learn more.
Top news stories from AMA Morning Rounds®: Week of March 6, 2023
In the news: Fatal opioid poisonings in children, lingering gastrointestinal problems after COVID infection, treatment for statin-intolerant patients and more.
10 most-viewed neurology residency programs
FREIDA™ users have tallied more than 155,000 views of neurology residency programs. Of the 175 neurology residencies listed, here are the 10 programs that rose to the top for user interest.
Top news stories from AMA Morning Rounds®: Week of May 9, 2022
In the news: COVID deaths surpass 1M in U.S., grim milestones drug overdose and firearm homicide rates, modifiable Alzheimer’s risk factors and more.
Top news stories from AMA Morning Rounds®: Week of April 4, 2022
In the news: U.S. a leader in preventable deaths of reproductive age women, obesity rose sharply among adults during the pandemic, COVID hospitalizations drop and more.
Brain researcher presented with AMA Distinguished Service Award
Carolyn Meltzer, MD honored for work in medical science and social advocacy.
Top news stories from AMA Morning Rounds®: Week of June 7, 2021
In the news: Administration urged to preserve telehealth expansion, FDA approves new Alzheimer’s treatment, COVID vaccines for kids, OSHA announces COVID safety rule.
Top news stories from AMA Morning Rounds®: Week of Nov. 30, 2020
In the news: Dementia and finance problems, CDC recommends first vaccine recipients, CDC shortens quarantine length, HHS allows telemedicine across state lines.